Understanding Your Lab and Genetic Reports

Navigating the laboratory and genetic reports for partial IRF8 deficiency can feel like learning a new language. These documents are the key to moving from a “suspected” diagnosis to a confirmed one. Because this condition involves subtle shifts in the immune system rather than a total loss of cells, the details in the fine print—specifically the absolute counts and the exact genetic “spelling”—are critical for your care team ^[1][2].

The Diagnostic Process

Diagnosis generally combines the clinical phenotype, a pathogenic or likely pathogenic IRF8 variant, immune-cell/functional findings, and sometimes family testing.

1. Genetic Sequencing

This test looks at the actual DNA code of the IRF8 gene. Patients may receive a targeted IEI panel, Whole Genome Sequencing (WGS), or Whole Exome Sequencing (WES) ^[3]. Note that WES may miss copy-number, deep-intronic, structural, or regulatory variants.

• Pathogenic Variant (ACMG/AMP): A change known to cause disease ^[4].

A Note on VUS (Variant of Uncertain Significance):
A VUS is a change that has been found, but scientists aren’t yet sure if it causes health problems ^[5]. A VUS does not confirm disease. It should not by itself drive major treatment, vaccine, or family decisions, and it may be reclassified over time. Direct these results to a clinical geneticist or genetic counselor for interpretation.

2. Advanced Flow Cytometry

While a standard blood test (CBC) might show a normal number of white blood cells, Flow Cytometry goes deeper ^[6]. It uses lasers to count specific subsets of cells based on their markers. For IRF8 deficiency, the lab looks specifically at dendritic cells and monocytes ^[1]. This is described as a supportive and specialized test rather than mandatory or universally available everywhere.

Key Technical Terms

Understanding these terms will help you interpret the “Results” section of your reports:

• Monocytopenia: A lower-than-normal number of monocytes ^[7]. In partial deficiency, this might be mild, whereas in complete deficiency, monocytes may be entirely absent ^[3].
• Absolute Count: The actual number of cells per microliter of blood. This is more important than the “percentage,” which only tells you how many cells there are relative to others.
• Zygosity: Tells you how many copies of the mutation you have. Heterozygous means you have one mutated copy (typical for partial deficiency); Homozygous or Compound Heterozygous means both copies are mutated (often seen in complete deficiency) ^[3][2].
• HGVS: The standard notation (e.g., c.1279dupT) used to exactly describe the genetic variant.

For Readers Who Want More Detail: Dendritic Cell Subsets

Dendritic cells (DCs) are the primary cells affected by IRF8 mutations. In specialized research settings, a report might break them down. Note that SIRPα alone is not a sufficient DC3 identifier in all labs, and findings vary:

• pDC: Often identified by CD123+/CD303+; these cells are vital for fighting viruses ^[2].
• cDC1: Typically reduced; these cells help the body recognize “foreign” invaders ^[8].
• cDC2: These cells require high levels of IRF8 and are often decreased ^[1].
• DC3: In partial deficiency, research indicates these cells often expand to “replace” the missing DC2s ^[1].

The Completeness Checklist

If your lab report is missing these data points, it may not provide the full picture.

• [ ] Absolute Counts: Does the report list the actual number (e.g., 0.02 x 10⁹/L) rather than just a percentage? ^[9]
• [ ] Age-Appropriate Reference Ranges: Are the results being compared to peers of the same age? ^[6]
• [ ] Genetic Notation: Does the genetic report include the HGVS nomenclature (e.g., c.1279dupT)? ^[2]
• [ ] VUS Review: If the variant is a VUS, has a specialist explained what targeted testing or family segregation is needed next?